• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VIIa 因子/组织因子引发的凝血的结构生物学。

Structural biology of factor VIIa/tissue factor initiated coagulation.

机构信息

Protein Science Laboratory, UCLA/Orthopaedic Hospital, Department of Orthopaedic Surgery, University of California, Los Angeles, CA 90095-1795, USA.

出版信息

Front Biosci (Landmark Ed). 2012 Jun 1;17(7):2476-94. doi: 10.2741/4066.

DOI:10.2741/4066
PMID:22652793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3383856/
Abstract

Factor VII (FVII) consists of an N-terminal gamma-carboxyglutamic acid domain followed by two epidermal growth factor-like (EGF1 and EGF2) domains and the C-terminal protease domain. Activation of FVII results in a two-chain FVIIa molecule consisting of a light chain (Gla-EGF1-EGF2 domains) and a heavy chain (protease domain) held together by a single disulfide bond. During coagulation, the complex of tissue factor (TF, a transmembrane glycoprotein) and FVIIa activates factor IX (FIX) and factor X (FX). FVIIa is structurally "zymogen-like" and when bound to TF, it is more "active enzyme-like." FIX and FX share structural homology with FVII. Three structural biology aspects of FVIIa/TF are presented in this review. One, regions in soluble TF (sTF) that interact with FVIIa as well as mapping of Ca2+, Mg2+, Na+ and Zn2+ sites in FVIIa and their functions; two, modeled interactive regions of Gla and EGF1 domains of FXa and FIXa with FVIIa/sTF; and three, incompletely formed oxyanion hole in FVIIa/sTF and its induction by substrate/inhibitor. Finally, an overview of the recognition elements in TF pathway inhibitor is provided.

摘要

因子 VII(FVII)由一个 N 端γ-羧基谷氨酸结构域组成,后面跟着两个表皮生长因子样(EGF1 和 EGF2)结构域和 C 端蛋白酶结构域。FVII 的激活导致由轻链(Gla-EGF1-EGF2 结构域)和重链(蛋白酶结构域)组成的双链 FVIIa 分子,它们通过一个二硫键连接在一起。在凝血过程中,组织因子(TF,一种跨膜糖蛋白)和 FVIIa 的复合物激活因子 IX(FIX)和因子 X(FX)。FVIIa 在结构上类似于“酶原”,当与 TF 结合时,它更像“活性酶”。FIX 和 FX 与 FVII 具有结构同源性。本文综述了 FVIIa/TF 的三个结构生物学方面。一是可溶性 TF(sTF)中与 FVIIa 相互作用的区域,以及 FVIIa 中 Ca2+、Mg2+、Na+和 Zn2+位点的作图及其功能;二是 FXa 和 FIXa 的 Gla 和 EGF1 结构域与 FVIIa/sTF 的模拟相互作用区域;三是 FVIIa/sTF 中不完全形成的氧阴离子空洞及其被底物/抑制剂诱导。最后,提供了 TF 途径抑制剂的识别元件概述。

相似文献

1
Structural biology of factor VIIa/tissue factor initiated coagulation.VIIa 因子/组织因子引发的凝血的结构生物学。
Front Biosci (Landmark Ed). 2012 Jun 1;17(7):2476-94. doi: 10.2741/4066.
2
The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.凝血因子IX和凝血因子X中的N端表皮生长因子样结构域是与组织因子结合的重要识别基序。
J Biol Chem. 2002 Feb 1;277(5):3622-31. doi: 10.1074/jbc.M111202200. Epub 2001 Nov 26.
3
Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.凝血因子X的γ-羧基谷氨酸(Gla)结构域和首个表皮生长因子样结构域在凝血酶原酶及组织因子-凝血因子VIIa复合物中的作用
J Biol Chem. 2003 Mar 21;278(12):10393-9. doi: 10.1074/jbc.M212144200. Epub 2003 Jan 15.
4
Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.将因子X中的γ-羧基谷氨酸(Gla)结构域替换为蛋白C的Gla结构域会损害其与因子VIIa/组织因子的相互作用:因子IX中类似替换缺乏可比效应。
J Biol Chem. 2007 May 25;282(21):15632-44. doi: 10.1074/jbc.M701908200. Epub 2007 Mar 26.
5
High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.对氨基苯甲脒和苯甲脒-VIIa/可溶性组织因子的高分辨率结构:192-193肽键的意外构象以及因子VIIa中Ca2+、Mg2+、Na+和Zn2+位点的定位
J Biol Chem. 2006 Aug 25;281(34):24873-88. doi: 10.1074/jbc.M509971200. Epub 2006 Jun 6.
6
The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.组织因子/因子VIIa/因子Xa复合物:通过对接和定点诱变构建的模型。
Proteins. 2003 Nov 15;53(3):640-8. doi: 10.1002/prot.10445.
7
Model of a ternary complex between activated factor VII, tissue factor and factor IX.活化因子VII、组织因子和因子IX之间三元复合物的模型。
Thromb Haemost. 2002 Jul;88(1):74-82.
8
The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.凝血因子Xa和凝血因子IXa的首个表皮生长因子样结构域对于激活凝血因子VII-组织因子复合物很重要。
J Thromb Haemost. 2005 Jan;3(1):112-8. doi: 10.1111/j.1538-7836.2004.01051.x.
9
Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.可溶性组织因子与全长组织因子对凝血因子VIIa的不同作用所涉及的分子决定因素。
Phys Chem Chem Phys. 2017 Aug 23;19(33):22230-22242. doi: 10.1039/c7cp02179h.
10
Structural modulation of factor VIIa by full-length tissue factor (TF): implication of novel interactions between EGF2 domain and TF.全长组织因子(TF)对因子 VIIa 的结构调节:EGF2 结构域与 TF 之间新的相互作用的意义。
J Biomol Struct Dyn. 2018 Feb;36(3):621-633. doi: 10.1080/07391102.2017.1289125. Epub 2017 Feb 17.

引用本文的文献

1
Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism.组织因子/因子VIIa复合物与X因子模拟物的冷冻电镜结构揭示了一种新型变构机制。
Blood. 2025 Aug 14. doi: 10.1182/blood.2025029430.
2
Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review.他汀类药物在抗凝治疗危及生命的急性静脉血栓栓塞症中的应用:综述。
Medicina (Kaunas). 2024 Jul 30;60(8):1240. doi: 10.3390/medicina60081240.
3
Site-directed mutagenesis of tissue factor pathway inhibitor-binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity.

本文引用的文献

1
Allosteric activation of coagulation factor VIIa.变构激活凝血因子 VIIa。
Front Biosci (Landmark Ed). 2011 Jun 1;16(8):3156-63. doi: 10.2741/3903.
2
Extensive small-angle X-ray scattering studies of blood coagulation factor VIIa reveal interdomain flexibility.广泛的小角度 X 射线散射研究表明,血液凝血因子 VIIa 具有结构域间的柔韧性。
Biochemistry. 2010 Nov 16;49(45):9739-45. doi: 10.1021/bi1011207. Epub 2010 Oct 20.
3
Understanding selectivity of hard and soft metal cations within biological systems using the subvalence concept. I. Application to blood coagulation: direct cation-protein electronic effects vs. indirect interactions through water networks.
凝血因子VII上组织因子途径抑制剂结合外位点D60A的定点诱变导致了一种具有较低凝血活性的新型凝血因子VII变体。
Res Pract Thromb Haemost. 2024 Jan 2;8(1):102309. doi: 10.1016/j.rpth.2023.102309. eCollection 2024 Jan.
4
Statins Effects on Blood Clotting: A Review.他汀类药物对凝血的影响:综述。
Cells. 2023 Nov 27;12(23):2719. doi: 10.3390/cells12232719.
5
Molecular Genetic Analysis of Russian Patients with Coagulation Factor FVII Deficiency.俄罗斯凝血因子 FVII 缺乏症患者的分子遗传学分析。
Genes (Basel). 2023 Sep 6;14(9):1767. doi: 10.3390/genes14091767.
6
Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia.组织因子途径抑制剂作为理解子痫前期病理生理学的潜在靶点。
Biomedicines. 2023 Apr 22;11(5):1237. doi: 10.3390/biomedicines11051237.
7
Comparative sequence analysis of vitamin K-dependent coagulation factors.维生素 K 依赖性凝血因子的比较序列分析。
J Thromb Haemost. 2022 Dec;20(12):2837-2849. doi: 10.1111/jth.15897. Epub 2022 Oct 11.
8
Alcohol functionality in the fatty acid backbone of sphingomyelin guides the inhibition of blood coagulation.鞘磷脂脂肪酸主链中的醇官能团可抑制血液凝固。
RSC Adv. 2021 Jan 15;11(6):3390-3398. doi: 10.1039/d0ra09218e. eCollection 2021 Jan 14.
9
Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.通过联合实验和计算方法揭示凝血因子的膜结合模型。
Thromb Haemost. 2021 Sep;121(9):1122-1137. doi: 10.1055/s-0040-1722187. Epub 2021 Jul 2.
10
Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization.凝血因子VII的新型突变(卡梅尔突变):鉴定与特征分析
Res Pract Thromb Haemost. 2021 Feb 25;5(4):e12407. doi: 10.1002/rth2.12407. eCollection 2021 May.
利用亚价概念理解生物系统中硬金属阳离子和软金属阳离子的选择性。I. 应用于血液凝固:阳离子与蛋白质的直接电子效应与通过水网络的间接相互作用。
J Chem Theory Comput. 2010 Mar 12;6(4):1048-1063. doi: 10.1021/ct100089s.
4
Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex.近期对因子 VIIa(FVIIa)/组织因子(TF)和因子 Xa(FXa)三元复合物结构的估算。
Thromb Res. 2010 Apr;125 Suppl 1:S7-S10. doi: 10.1016/j.thromres.2010.01.022. Epub 2010 Feb 13.
5
Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium.镁在因子XIa催化因子IX激活中的作用:生理镁浓度下钙与因子IX的结合
J Thromb Haemost. 2009 Aug;7(8):1426-8. doi: 10.1111/j.1538-7836.2009.03506.x. Epub 2009 Jun 3.
6
CHARMM: the biomolecular simulation program.CHARMM:生物分子模拟程序。
J Comput Chem. 2009 Jul 30;30(10):1545-614. doi: 10.1002/jcc.21287.
7
Loop dynamics of the extracellular domain of human tissue factor and activation of factor VIIa.人组织因子细胞外结构域的环动力学与凝血因子VIIa的激活
Biophys J. 2009 Jan;96(2):681-92. doi: 10.1016/j.bpj.2008.10.018.
8
Mg(2+) binding to the Gla domain of factor X influences the interaction with tissue factor.镁离子与凝血因子X的γ-羧基谷氨酸结构域结合会影响其与组织因子的相互作用。
J Thromb Haemost. 2007 Sep;5(9):1977-8. doi: 10.1111/j.1538-7836.2007.02661.x.
9
Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.将因子X中的γ-羧基谷氨酸(Gla)结构域替换为蛋白C的Gla结构域会损害其与因子VIIa/组织因子的相互作用:因子IX中类似替换缺乏可比效应。
J Biol Chem. 2007 May 25;282(21):15632-44. doi: 10.1074/jbc.M701908200. Epub 2007 Mar 26.
10
Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X.鉴定组织因子上与因子X的第一个表皮生长因子样结构域相互作用的一个碱性区域。
Biochemistry. 2007 Mar 20;46(11):3193-9. doi: 10.1021/bi6025193. Epub 2007 Feb 27.